We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Prescription arbitrage

3 September 2020 By Robert Cyran

America’s medical system is expensive, opaque and complex. That makes it a great place for a middleman like GoodRx. The drug discount finder is growing nearly 50% annually and has 33% operating margins. The big risk is a serious political push toward simpler, cheaper options.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)